<SEC-DOCUMENT>0001213900-24-050751-index.html : 20240607
<SEC-HEADER>0001213900-24-050751.hdr.sgml : 20240607
<ACCEPTANCE-DATETIME>20240607160055
ACCESSION NUMBER:		0001213900-24-050751
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		12
FILED AS OF DATE:		20240607
DATE AS OF CHANGE:		20240607
EFFECTIVENESS DATE:		20240607

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Jasper Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001788028
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				842984849
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-280039
		FILM NUMBER:		241029156

	BUSINESS ADDRESS:	
		STREET 1:		2200 BRIDGE PKWY SUITE #102
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94065
		BUSINESS PHONE:		6505491400

	MAIL ADDRESS:	
		STREET 1:		2200 BRIDGE PKWY SUITE #102
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94065

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Amplitude Healthcare Acquisition Corp
		DATE OF NAME CHANGE:	20190912
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>ea0207285-s8_jasper.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
Document 1 - file: ea0207285-s8_jasper.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>2
<FILENAME>ea020728501ex4-3_jasper.htm
<DESCRIPTION>JASPER THERAPEUTICS, INC. 2024 EQUITY INCENTIVE PLAN
<TEXT>
Document 2 - file: ea020728501ex4-3_jasper.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>3
<FILENAME>ea020728501ex4-4_jasper.htm
<DESCRIPTION>FORM OF STOCK OPTION AWARD AGREEMENT UNDER THE JASPER THERAPEUTICS, INC. 2024 EQUITY INCENTIVE PLAN
<TEXT>
Document 3 - file: ea020728501ex4-4_jasper.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>4
<FILENAME>ea020728501ex4-5_jasper.htm
<DESCRIPTION>FORM OF RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE JASPER THERAPEUTICS, INC. 2024 EQUITY INCENTIVE PLAN
<TEXT>
Document 4 - file: ea020728501ex4-5_jasper.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.6
<SEQUENCE>5
<FILENAME>ea020728501ex4-6_jasper.htm
<DESCRIPTION>FORM OF RESTRICTED STOCK AWARD AGREEMENT UNDER THE JASPER THERAPEUTICS, INC. 2024 EQUITY INCENTIVE PLAN
<TEXT>
Document 5 - file: ea020728501ex4-6_jasper.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.7
<SEQUENCE>6
<FILENAME>ea020728501ex4-7_jasper.htm
<DESCRIPTION>JASPER THERAPEUTICS, INC. 2024 EMPLOYEE STOCK PURCHASE PLAN
<TEXT>
Document 6 - file: ea020728501ex4-7_jasper.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>7
<FILENAME>ea020728501ex5-1_jasper.htm
<DESCRIPTION>OPINION OF PAUL HASTINGS LLP
<TEXT>
Document 7 - file: ea020728501ex5-1_jasper.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>8
<FILENAME>ea020728501ex23-1_jasper.htm
<DESCRIPTION>CONSENT OF PRICEWATERHOUSECOOPERS LLP
<TEXT>
Document 8 - file: ea020728501ex23-1_jasper.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>9
<FILENAME>ea020728501ex-fee_jasper.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
Document 9 - file: ea020728501ex-fee_jasper.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 10 - file: ex5-1_001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex5-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 11 - file: ex5-1_002.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ex5-1_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 12 - file: ex5-1_003.jpg

</DOCUMENT>
</SEC-DOCUMENT>